On 27th July 2020, the Ministry of Electronics and Information Technology (MeitY) introduced PLI or Production Linked Incentive Scheme for pharmaceutical manufacturing. Which of the following points is/are covered under this scheme? 1. Production Linked Incentives of up to INR 6,940 crores have been approved 2. A financial incentive will be given to eligible manufacturers of identified 41 eligible products which cover 53 APIs, for 6 years, committed investment and sales made by the selected applicant for the eligible products. 3. The Net Worth of the Applicant (including that of Group Companies), as on the date of application, shall not be less than 30% of the total committed investment. 4. The scheme shall be operational during the period FY 2020-2021 to 2024-2025. Select the correct answer using the code given below. (A) 1 only (B) 2 only (C) 3 and 4 (D) 4 only

On 27th July 2020, the Ministry of Electronics and Information Technology (MeitY) introduced PLI or Production Linked Incentive Scheme for pharmaceutical manufacturing. Which of the following points is/are covered under this scheme? 1. Production Linked Incentives of up to INR 6,940 crores have been approved 2. A financial incentive will be given to eligible manufacturers of identified 41 eligible products which cover 53 APIs, for 6 years, committed investment and sales made by the selected applicant for the eligible products. 3. The Net Worth of the Applicant (including that of Group Companies), as on the date of application, shall not be less than 30% of the total committed investment. 4. The scheme shall be operational during the period FY 2020-2021 to 2024-2025. Select the correct answer using the code given below. (A) 1 only (B) 2 only (C) 3 and 4 (D) 4 only Correct Answer D

Related Questions

The following are the criteria set by a Retail outlet for the selection of candidates for the post of Store In charge in a reputed mall. 1. The candidate must be a graduate in any stream with minimum of 50% marks. 2. The candidate must have Minimum of 5 years of Sales experience in Retail. 3. The age of the candidate should not be less than 25 years and more than 34 years as on 1st October, 2019. (a) If a candidate satisfies all the criteria except 2 as given above but has an MBA degree and has minimum of 2 years of work experience in sales, she/he must be sent to the General Manager, Recruitment for further interview. (b) If a candidate satisfies all the criteria except 3, but has more than 5 years experience as a Group Manager and above in Sales managing a team of sales executives, then she/he must be sent to the Regional Manager, Sales & Marketing, for further interview Based on the above criteria and conditions, analyze and decide which of the following course of action should be taken for the candidate whose description is provided below. Please note that you are not to assume anything other than the given information. Sujoy is a graduate with 55% marks and MBA through Correspondence. He was born on Sept 20, 1990. He has 1 year of work experience as a sales executive and 2 years of experience as a Group Manager, Sales. On the basis of the information as given above, which of the following decisions would be appropriate
In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the suggested courses of action logically follow (s) for pursuing. Statement: With one year to go for 2019 parliamentary elections, Prime Minister Narendra Modi has stepped in to ensure results can be seen on the ground. The Centre has asked states to focus on impactful and public-private-partnership based smart city projects, which would show results over the next one year and have a review mechanism in place. Ministry of housing and urban affairs, the nodal ministry for Smart Cities Mission has identified 261 impactful ventures worth Rs. 31,000 crore and PPP projects worth Rs. 32,000 crore for the states to work on. Courses of Action: I. The move follows directives from the Prime Minister. During a review of Smart Cities mission last week, PM Modi had emphasized on early implementation of projects and suggested that the chief secretaries of all states should review the progress of the implementation. II. These identified projects account for an investment of Rs. 31,112 crore. The states have also been asked to work on 370 PPP projects that involve an investment of Rs. 32,410 crore The impactful projects identified range from building 40 outdoor fitness centres in New Delhi Municipal Council area at a cost of Rs. 1.31 crore to redevelopment of 340 acre area in Bhopal at a cost of Rs. 3,000 crore.  III. Secretary (housing and urban affairs) D. S. Mishra has written to chief secretaries of states and asked them to focus on the belated implementation of smart city projects that have a visible and transformative impact in the lives of citizens in identified smart cities.
In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the suggested courses of action logically follow(s) for pursuing. Statement: India’s pharmaceutical sector is now popping out from a shell and making a remarkable recovery. Actually, it has been facing several regulatory challenges in the forms of a recast of foreign direct investment (FDI) policy, pricing policy in the US generics market, patent protection, regulatory approvals and compulsory licensing. Also limited new product launches in the generics space, GST introduction and higher costs associated with regulatory compliance have hurt the sector. Courses of action: I. The government has been engrossed more in policy making and taking resilient decisions for the concerns of the pharma industry. Recently, the government proposed to introduce a new price index for pharmaceutical products, which would serve as a benchmark for determining prices of all medicines sold in the country. II. Meanwhile, pharma companies’ constant investments in R&D have enabled them to develop a basket of robust products for markets across the world. In international markets, pricing pressure on generics sold in the US has eased and this is likely to support the sector. III. Domestic pharma sales grew to Rs. 10,583 crore in May 2018 from Rs. 9,549 crore in the same month last year. The recent clearance by the US Food and Drug Administration to Sun Pharma’s manufacturing plant at Halol in Gujarat brings to an end a two-year import ban it had imposed on the company over quality issues. This is likely to increase sales for the company.